IQVIA, a global provider of advanced analytics, clinical research services and technology solutions, announced it has expanded its partnership with tech company Salesforce to help expand its customer engagement platform for the life sciences industry.
The companies will utilize IQVIA’s Orchestrated Customer Engagement Platform, including its data and analytics, and Salesforce’s CRM to develop the Salesforce Life Sciences Cloud for customer engagement.
IQVIA is licensing its engagement platform and related software to Salesforce to develop the offering, which is slated to be available in 2025. The companies will work jointly to market the new offering.
“Our expanded relationship with Salesforce will bring the best of our combined capabilities in data, AI and technology to life sciences customers. In collaboration with various strategic partners across multiple healthcare verticals, IQVIA will continue to develop innovative technology solutions to help accelerate decision making across discovery, clinical development, medical affairs, real-world evidence generation, patient safety, regulatory compliance, patient engagement and commercial operations,” Bernd Haas, SVP and head of digital products and solutions at IQVIA, said in a statement.
THE LARGER TREND
In March, Salesforce announced the launch of Einstein Copilot: Health Actions, a conversational AI platform that answers providers’ questions based on an organization’s own data. The platform also automates clinical summaries and generates patient assessments for care teams.
Other companies using AI in the life sciences sector include Microsoft, Israel-based AION Labs and tech giant Dell.
